Xu XJ, Zhang J, Li M, Hou JQ. Clinical study on the minimally invasive percutaneous nephrolithotomy treatment of upper urinary calculi. World J Clin Cases 2022; 10(4): 1198-1205 [PMID: 35211553 DOI: 10.12998/wjcc.v10.i4.1198]
Corresponding Author of This Article
Jian-Quan Hou, MD, Chief Physician, Department of Urology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Road, Suzhou 215006, Jiangsu Province, China. houjianquan2011@163.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Feb 6, 2022; 10(4): 1198-1205 Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1198
Clinical study on the minimally invasive percutaneous nephrolithotomy treatment of upper urinary calculi
Xiao-Jian Xu, Jun Zhang, Miao Li, Jian-Quan Hou
Xiao-Jian Xu, Jun Zhang, Miao Li, Jian-Quan Hou, Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China
Author contributions: Xu XJ and Zhang J contributed equally to this study, and are the co-first authors of this article; Xu XJ, Zhang J and Hou JQ designed this retrospective study; Xu XJ and Zhang J wrote the paper; Xu XJ, Zhang J, Li M and Hou JQ were responsible for sorting the data.
Institutional review board statement: This study was approved by the Ethics Committee of the First Affiliated Hospital of Suzhou University.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: No conflict of interest.
Data sharing statement: No additional data.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Quan Hou, MD, Chief Physician, Department of Urology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Road, Suzhou 215006, Jiangsu Province, China. houjianquan2011@163.com
Received: October 15, 2021 Peer-review started: October 15, 2021 First decision: December 1, 2021 Revised: December 2, 2021 Accepted: December 25, 2021 Article in press: December 25, 2021 Published online: February 6, 2022 Processing time: 100 Days and 22 Hours
ARTICLE HIGHLIGHTS
Research background
Upper urinary tract stones are very common in China. However, there are few clinical reports on the impact of minimally invasive percutaneous nephrolithotomy (mPCNL) on patients with inflammatory factors, and because of the different levels of technology, some minimally invasive surgeries have frequent postoperative complications.
Research motivation
The authors studied the mPCNL on upper urinary tract stones and its influence on the renal function of patients.
Research objectives
This study aimed to observe the therapeutic effect of mPCNL on upper urinary tract stones.
Research methods
The authors selected patients as research subjects and were divided into the PCNL group and the mPCNL group.
Research results
The Qmax level of the mPCNL group was higher than that of the PCNL group.
Research conclusions
mPCNL has a good therapeutic effect on upper urinary tract stones.
Research perspectives
The purpose of this study was to further confirm the therapeutic effect of mPCNL in upper urinary calculi.
